Heart Failure Risk Reduction in Diabetes: What the Practicing Endocrinologist Should Know

Join the experts at this live webinar as they discuss leveraging the cardioprotective effects of SGLT2 inhibitors to reduce heart failure risk in your patients with type 2 diabetes.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

This activity is supported by an independent educational grant from

Boehringer Ingelheim and Eli Lilly